Albany, NY -- (SBWIRE) -- 02/12/2014 -- Clostridium is a gram-positive bacteria which belongs to phylum Firmicutes, it’s an obligate anaerobe capable of producing endospores. Clostridium botulinium, Clostridium difficle, Clostridium perfringens, Clostridium tetani and Clostridium sordellii are the different species of clostridium responsible for diseases in humans. Clostridium tetani is the etiological agent of tetanus, Clostridium botulinum is the etiological agent of botulism, Clostridium perfringes is one of the etiological agents of gas gangrene, Clostridium sortellii is capable of causing pneumonia, endocarditis, arthritis, peritonitis, and myonecrosis and Clostridium difficle is etiological agent of diarrhea.
Browse Full Report with TOC: http://www.transparencymarketresearch.com/clostridium-diagnostics-market.html
The global clostridium diagnostics market can be segmented as follows:
- Diagnostic tests
- Fluorescent-Antibody Assays
- Poloymerase Chain Reactions
- Emerging Diagnostic Technologies
- DNA Probes
- Monoclonal antibodies
- Differential Light Scattering
- Microcomputers and Automation
- Artificial Intelligence
- Flow Cytometry
- Gel Microdroplets
Clostridium diagnostics market is driven by rising population, growing awareness about clostridium related disorders and technological developments in diagnostics equipment like artificial intelligence and automation.
Prevalence of clostridium and its different species was observed more in North America and Europe compared to Asia-Pacific and Rest of World. Thus, North America currently leads this market and is followed by Europe. Asia-Pacific is a growing market for clostridium diagnostics with rapid economic development, growth in awareness about critical diseases and their prevention and highly populated countries in the world such as China and India with mediocre or developing healthcare infrastructure. Brazil and Gulf countries are considered to drive the clostridium diagnostics market in Rest of World.
Some of the major companies contributing to the global clostridium diagnostics market include Abbott Laboratories, Beckman Coulter, Inc., Biochem Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc., Olympus Corporation, F. Hoffmann-La Roche Ltd, Siemens and others.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Read More Reports on Medical Devices Markets: http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
About Transparency Market Research (TMR)
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information.Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
90 State Street,
Albany NY - 12207
Browse Market Research Blog: